Mira DX
MiraDx, based in New Haven, CT, specializes in shaping personalized cancer treatments by tailoring care plans according to individual patient responses and toxicity profiles. The company's innovative approach leverages groundbreaking genetic research and microRNA biomarkers to enhance therapy outcomes and improve the quality of life for cancer patients.
Co-founded by renowned researchers Frank Slack, PhD, and Joanne Weidhaas, MD, PhD, MiraDx focuses on developing diagnostic tests like PROSTOX and PREVIOTOX to assess risks associated with cancer treatments. These advancements empower physicians to make informed decisions, ultimately leading to safer and more effective cancer care strategies.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.